FPI Based Force Sensor for Prostate Biopsy Needle Interventions under MRI

Author(s):  
Dogangun Uzun ◽  
Okan Ulgen ◽  
Ozgur Kocaturk
2005 ◽  
Vol 4 (3) ◽  
pp. 157
Author(s):  
M. Auprich ◽  
H. Augustin ◽  
S. Mannweiler ◽  
P. Rehak ◽  
G. Tilz ◽  
...  

2013 ◽  
Vol 27 (3) ◽  
pp. 277-283 ◽  
Author(s):  
Gideon Lorber ◽  
Mordechai Duvdevani ◽  
Michael Friedman ◽  
Eran Lavy ◽  
Ezekiel H. Landau ◽  
...  

2013 ◽  
Vol 7 (9-10) ◽  
pp. 567 ◽  
Author(s):  
Antonio Cicione ◽  
Francesco Cantiello ◽  
Cosimo De Nunzio ◽  
Andrea Tubaro ◽  
Rocco Damiano

Background: Biopsy Gleason score (GS), in combination with other clinical parameters, is important to take a therapeutic decision for patients with diagnosis of localized prostate cancer. However, preoperative GS is often upgraded after a radical prostatectomy. Increasing the amount of tissue in prostate biopsy may be a way to avoid this issue. We evaluate the influence of a larger biopsy needle size on the concordance between biopsy and pathological GS.Methods: We analyzed paired biopsies and prostatectomy specimens from 104 cases of men with clinically localized prostate cancer. At the time of prostate biopsy, the patients were prospectively randomized into two needle groups (16-Gauge [G] and 18G) using a 1:1 ratio. GS concordance was estimated performing kappa statistic testing, overall concordance rate and risk to under grade biopsy GS=6. A logistic regression analysis was performed to evaluate the patients’ characteristics as possible risk factors.Results: The overall concordance between prostate biopsy and pathological GS was 76.9% and 75.6% (p = 0.875) and the k values were 0.821 and 0.811 (p = 0.424), respectively, for 16G and 18G needle study groups. The risk to undergrade a biopsy GS=6 was 21.1% and 15.4% (p = 0.709) using a 16G and 18G needle, respectively. Age, prostate-specific antigen, prostate volume and needle calibre were not independently associated with a higher risk of GS discordance.Conclusions: Needle size does not affect the concordance between biopsy and pathological GS. Although GS is not the only way to determine treatment, it is still an unresolved urological issue.


2007 ◽  
Vol 28 (8) ◽  
pp. 916-919 ◽  
Author(s):  
William A. Rutala ◽  
Maria F. Gergen ◽  
David J. Weber

Background.Transrectal ultrasound (TRUS)-guided prostate biopsies are among the most common outpatient diagnostic procedures in urology clinics and carry the risk of introducing pathogens that may lead to infection.Objective.To investigate the effectiveness of procedures for disinfecting a probe used in ultrasound-guided prostate biopsy.Method.The effectiveness of disinfection was determined by inoculating 107 colony forming units (cfu) of Pseudomonas aeruginosa at the following 3 sites on the probe: the interior lumen of the biopsy needle guide, the outside surface of the biopsy needle guide, and the interior lumen of the ultrasound probe where the needle guide passes through the transducer. Each site was investigated separately. After inoculation, the probe was immersed in 2% glutaraldehyde for 20 minutes and then assessed for the level of microbial contamination.Results.The results demonstrated that disinfection (ie, a reduction in bacterial load of greater than 7 log10 cfu) could be achieved if the needle guide was removed from the probe. However, if the needle guide was left in the probe channel during immersion in 2% glutaraldehyde, disinfection was not achieved (ie, the reduction was approximately 1 log10 cfu).Conclusions.Recommendations for probe disinfection are provided and include disassembling the device and immersing the probe and the needle guide separately in a high-level disinfectant.


2018 ◽  
Vol 63 (20) ◽  
pp. 20NT02 ◽  
Author(s):  
Pedro Moreira ◽  
Niravkumar Patel ◽  
Marek Wartenberg ◽  
Gang Li ◽  
Kemal Tuncali ◽  
...  

2021 ◽  
Author(s):  
Davut Ibrahim Mahcicek ◽  
Dursun Korel Yildirim ◽  
Gokce Kasaci ◽  
Ozgur Kocaturk

Abstract In clinical routine, the prostate biopsy procedure is performed with the guidance of transrectal ultrasound (TRUS) imaging to diagnose prostate cancer. However, the TRUS-guided prostate biopsy brings reliability concerns due to the lack of contrast difference between prostate tissue and lesions. In this study, a novel hydraulic needle delivery system that is designed for performing MRI-guided prostate biopsy procedure with transperineal approach is introduced. The feasibility of the overall system was evaluated through in-vitro phantom experiments under an MRI guidance. The in vitro experiments performed using a certified prostate phantom (incorporating MRI visible lesions). MRI experiments showed that overall hydraulic biopsy needle delivery system has excellent MRI compatibility (SNR Loss < 3%), provides acceptable targeting accuracy (average 2.05±0.46 mm) and procedure time (average 40 minutes).


2017 ◽  
Vol 16 (11) ◽  
pp. e2839
Author(s):  
M.J. Sieczkowski ◽  
A. Gibas ◽  
A. Wasik ◽  
A. Kot-Wasik ◽  
L. Piechowicz ◽  
...  

2017 ◽  
Vol 16 (6) ◽  
pp. 1038-1043 ◽  
Author(s):  
Marcin Sieczkowski ◽  
Artur Gibas ◽  
Andrzej Wasik ◽  
Agata Kot-Wasik ◽  
Lidia Piechowicz ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document